Innovative Therapies and Clinical Studies for Screenable Disorders (R01, R03 and R21 - three separate programs)

CLOSING DATE:

Letter of Intent: 30 days prior to the application date

Multiple closing dates - please see this link for details: http://grants.nih.gov/grants/funding/submissionschedule.htm.

AMOUNT:

Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.

ELIGIBLE APPLICANTS:

For-profit and nonprofit organizations; public or private institutions such as universities, colleges, hospitals and laboratories; units of federal, state and local governments; and domestic or foreign institution/organizations.

AGENCY/DEPARTMENT:

National Institutes of Health (NIH)

SUMMARY:

Applications are invited for research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future.

LISTED IN:

www.grants.gov

FOR DETAILED INFORMATION GO TO:

http://grants.nih.gov/grants/guide/pa-files/PAR-06-060.html

http://grants.nih.gov/grants/guide/pa-files/PAR-06-061.html

http://grants.nih.gov/grants/guide/pa-files/PAR-06-059.html